L A Petersen1, S L Normand, L L Leape, B J McNeil. 1. Houston Center for Quality of Care and Utilization Studies, a Health Services Research and Development Center of Excellence, Houston VAMedical Center, Houston, TX 77030, USA. laurap@bcm.tmc.edu.
Abstract
BACKGROUND: There is concern that care provided in the Veterans Health Administration (VA) may be of poorer quality than non-VA health care. We compared use of medications after acute myocardial infarction in the VA with that in non-VA healthcare settings under fee-for-service (FFS) Medicare financing. METHODS AND RESULTS: We used clinical data from 2486 VA and 29 249 FFS men >65 years old discharged with a confirmed diagnosis of acute myocardial infarction from 81 VA hospitals and 1530 non-VA hospitals. We reported odds ratios (ORs) for use of thrombolytics, beta-blockers, ACE inhibitors, or aspirin among ideal candidates adjusted for age, sample design (hospital academic affiliation, availability of cardiac procedures, and volume), and within-hospital clustering. Ideal VA candidates were more likely to undergo thrombolytic therapy at arrival (OR [VA relative to Medicare] 1.40 [1.05, 1.74]) or to receive ACE inhibitors (OR 1.67 [1.12, 2.45]) or aspirin (OR 2.32 [1.81, 3.01]) at discharge and equally likely to receive beta-blockers (OR 1.09 [1.03, 1.40]) at discharge. CONCLUSIONS: Ideal candidates in VA were at least as likely as those in FFS to receive medical therapies of known benefit for acute myocardial infarction.
BACKGROUND: There is concern that care provided in the Veterans Health Administration (VA) may be of poorer quality than non-VA health care. We compared use of medications after acute myocardial infarction in the VA with that in non-VA healthcare settings under fee-for-service (FFS) Medicare financing. METHODS AND RESULTS: We used clinical data from 2486 VA and 29 249 FFS men >65 years old discharged with a confirmed diagnosis of acute myocardial infarction from 81 VA hospitals and 1530 non-VA hospitals. We reported odds ratios (ORs) for use of thrombolytics, beta-blockers, ACE inhibitors, or aspirin among ideal candidates adjusted for age, sample design (hospital academic affiliation, availability of cardiac procedures, and volume), and within-hospital clustering. Ideal VA candidates were more likely to undergo thrombolytic therapy at arrival (OR [VA relative to Medicare] 1.40 [1.05, 1.74]) or to receive ACE inhibitors (OR 1.67 [1.12, 2.45]) or aspirin (OR 2.32 [1.81, 3.01]) at discharge and equally likely to receive beta-blockers (OR 1.09 [1.03, 1.40]) at discharge. CONCLUSIONS: Ideal candidates in VA were at least as likely as those in FFS to receive medical therapies of known benefit for acute myocardial infarction.
Authors: David U Himmelstein; Karen E Lasser; Danny McCormick; David H Bor; J Wesley Boyd; Steffie Woolhandler Journal: Am J Public Health Date: 2007-10-30 Impact factor: 9.308
Authors: William M Tierney; J Marc Overhage; Michael D Murray; Lisa E Harris; Xiao-Hua Zhou; George J Eckert; Faye E Smith; Nancy Nienaber; Clement J McDonald; Fredric D Wolinsky Journal: J Gen Intern Med Date: 2003-12 Impact factor: 5.128
Authors: Adeel A Butt; Joel Tsevat; Anthony C Leonard; Obaid S Shaikh; Deborah McMahon; Uzma A Khan; Zachariah Dorey-Stein; Vincent Lo Re Journal: Int J Infect Dis Date: 2008-11-06 Impact factor: 3.623